Pardaxin-6

General Information


DRACP ID  DRACP00455

Peptide Name   Pardaxin-6

Sequence  GFFALIPKIISSPLFKTLLSAVGSALS

Sequence Length  27

UniProt ID  P81865  P81862  P81861 

PubChem CID  Not available

Origin  Epinephelus nebulosus

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma ~72% Cytotoxicity=25 mg/L MTS assay 6 h 1
HT-1080 Fibrosarcoma Sarcoma ~84% Cytotoxicity=25 mg/L MTS assay 6 h 1

Hemolytic Activity  The HL50 values of Pardaxin-6 (about 100 mg/L) were much higher than those of EP-1 and EP-9

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00455

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C134H217N29O34

Absent amino acids  CDEHMNQRWY

Common amino acids  LS

Mass  324231

Pl  10.81

Basic residues  2

Acidic residues  0

Hydrophobic residues  15

Net charge  2

Boman Index  2898

Hydrophobicity  125.93

Aliphatic Index  137.41

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  8

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23598079

Title  Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus

Doi 10.1016/j.peptides.2013.04.004

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.